An Italian software company says it has developed a way to detect COVID-19 infections by analyzing a person's speech or cough with no need for a blood test, nose, or anal swab.
Neosperience President Dario Melpignano said Tuesday the system, which detects sounds characteristic of the respiratory disease, was more than 80% accurate. The announcement sent the company's shares up more than 13%.
The project was developed with partners and by using artificial intelligence (AI) embedded in a cloud platform called Neosperience Health Cloud, which has already been used to analyze chest x-rays, the company said in a statement.
Neosperience's shares, listed on the Aim section of the Milan Bourse, were automatically suspended after rising 13.5% to 6.50 euros ($7.69) per share.
"It's just the beginning of a project that has incredible potential because the processing of this sort of data can be effectively used as a screening test," said Alessandro Nizardo Chailly, the chief executive of Neosperience's partner Capsula.
The recording and analysis model could help to detect and diagnose a wide range of pathogens, added Capsula's scientific adviser Giuseppe Andreoni.
Please click to read our informative text prepared pursuant to the Law on the Protection of Personal Data No. 6698 and to get information about the cookies used on our website in accordance with the relevant legislation.
6698 sayılı Kişisel Verilerin Korunması Kanunu uyarınca hazırlanmış aydınlatma metnimizi okumak ve sitemizde ilgili mevzuata uygun olarak kullanılan çerezlerle ilgili bilgi almak için lütfen tıklayınız.